HHS says it may revisit policy for anti-obesity drugs
The government said it “may consider future policy options” for anti-obesity medications, after declining to finalize a Biden-era proposal that would have expanded coverage to millions of Medicare patients. An HHS spokesperson told Endpoints News ...
